Literature DB >> 10022622

Hyperbaric oxygen therapy for perineal Crohn's disease.

C M Noyer1, L J Brandt.   

Abstract

Perineal lesions are a frequent and troublesome complication of Crohn's disease. Although there are various surgical and medical therapeutic regimens available to treat these lesions, all have significant associated morbidity, mortality, and toxicity. Recently, the beneficial effects of hyperbaric oxygen therapy (HBOT) have been described in patients with severe or refractory perineal disease, but the role of HBOT in larger groups or less severely affected patients has not yet been studied, nor has the minimum number of treatments required for initial or complete healing of perineal disease in this population been described. This article reviews the known and theoretical tissue effects of HBOT and discusses its potential role in treating patients with perineal Crohn's disease.

Entities:  

Mesh:

Year:  1999        PMID: 10022622     DOI: 10.1111/j.1572-0241.1999.00848.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

1.  Inflammatory Bowel Disease After Age 60.

Authors:  David A. Greenwald; Lawrence J. Brandt
Journal:  Curr Treat Options Gastroenterol       Date:  2003-06

Review 2.  Emerging treatments for complex perianal fistula in Crohn's disease.

Authors:  Carlos Taxonera; David A Schwartz; Damián García-Olmo
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

3.  Hyperbaric oxygenation ameliorates indomethacin-induced enteropathy in rats by modulating TNF-alpha and IL-1beta production.

Authors:  Z Yang; J Nandi; J Wang; G Bosco; M Gregory; C Chung; Y Xie; X Yang; E M Camporesi
Journal:  Dig Dis Sci       Date:  2006-07-13       Impact factor: 3.199

4.  Perianal Fistulas in Patients With Crohn's Disease, Part 1: Current Medical Management.

Authors:  Stephanie L Gold; Shirley Cohen-Mekelburg; Yecheskel Schneider; Adam Steinlauf
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-08

5.  Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis.

Authors:  Daniel A Rossignol
Journal:  Med Gas Res       Date:  2012-03-15

6.  Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease.

Authors:  Gaurav Agrawal; Thomas Borody; Robert Turner; Sharyn Leis; Jordana Campbell
Journal:  Future Sci OA       Date:  2015-09-28

Review 7.  Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.

Authors:  A Hillary Steinhart; Remo Panaccione; Laura Targownik; Brian Bressler; Reena Khanna; John K Marshall; Waqqas Afif; Charles N Bernstein; Alain Bitton; Mark Borgaonkar; Usha Chauhan; Brendan Halloran; Jennifer Jones; Erin Kennedy; Grigorios I Leontiadis; Edward V Loftus; Jonathan Meddings; Paul Moayyedi; Sanjay Murthy; Sophie Plamondon; Greg Rosenfeld; David Schwartz; Cynthia H Seow; Chadwick Williams
Journal:  J Can Assoc Gastroenterol       Date:  2018-09-14

8.  Hyperbaric Oxygen Increases Stem Cell Proliferation, Angiogenesis and Wound-Healing Ability of WJ-MSCs in Diabetic Mice.

Authors:  Isaac Peña-Villalobos; Ignacio Casanova-Maldonado; Pablo Lois; Catalina Prieto; Carolina Pizarro; José Lattus; Germán Osorio; Verónica Palma
Journal:  Front Physiol       Date:  2018-07-30       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.